Popular Articles

Micromet Presents Update On Blinatumomab's Response Rate And Duration In A Phase 1 Study In Non-Hodgkin's Lymphoma Patients
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, last week presented an update from an ongoing clinical study of the BiTE(R) antibody blinatumomab (MT103) for non-Hodgkin"s lymphoma (NHL) at the 14th Congress of the European Hematology Association (EHA), held June 4 to 7 in Berlin, Germany. Blinatumomab is a novel therapeutic antibody that activates a patient"s T cells to seek out and destroy cancer cells.
generic viagra online
Wall Street Journal Examines Project Aimed At Delivering Drinking Water To Populations In India, China
The Wall Street Journal examines how a "rainwater harvesting project," called Aakash Ganga is delivering water to India"s northern state of Rajasthan - one of the driest states in India - and expanding into China"s Guiyang Municipality. The original project, supported by the World Bank, is set to expand from six villages in Rajasthan to "70 villages, to provide water security to 200,000 people," the newspaper writes.
News of the day
Three In Every One Thousand U.S. Children Diagnosed With Tourette Syndrome
The first-ever national estimate among a nationally representative sample of U.S. children revealed that 3 out of every 1,000 children between the age of 6 and 17 in the United States have been diagnosed with Tourette Syndrome (TS), according to a study by the Centers for Disease Control and Prevention (CDC) released in the Morbidity and Mortality Weekly Report.
Endocrinology

Legislation Protecting Patients From Losing Health Insurance When They Get Sick Clears Senate Policy Committee

Legislation protecting patients from the practice of health insurers and health plans canceling their coverage when they get seriously ill today passed the Senate Judiciary Committee. Assembly Bill 2, sponsored by the California Medical Association and authored by Assemblymember Hector De La Torre, D-Southgate, is designed to prevent the outrageous industry-wide practice of health plans wrongfully rescinding coverage for patients. The bill, which has already been approved by the Assembly and the Senate Health Committee, moves next to the Senate Appropriations Committee. Over the last few years, rescissions have become common practice for HMOs and insurers. The reprehensible conduct has produced lawsuits, fines, legal settlements and a congressional investigation - all after the fact. The problem, however, still remains that patients can get their health coverage pulled out from under them just when they need it most, when they are severely sick and their medical bills are mounting. Rescissions cause immense emotional and financial suffering for those involved, even when it is unjustified. AB 2 takes a proactive approach, continuing insurance coverage until an independent board reviews the matter and makes a decision as to whether it is legal. "The whole country is talking about health care reform," said Dr. Dev GnanaDev, president of the California Medical Association. "Part of reforming the system must include stopping this insidious practice and ensuring that Californians get health insurance they can count on. We need to prevent health plans and insurers from leaving their patients stranded when they most need coverage. Rescissions only lead to increasing medical costs for the patient, doctor and hospital while the insurer makes a profit." The measure also raises the legal standard for rescission by stipulating that in order to cancel coverage, the health plan or insurer must have completed medical underwriting for the patient involved and show that the patient willfully misrepresented information. This provision would prevent patients who make innocent mistakes, such as forgetting to include information about long-ago medical conditions, from losing their insurance. California Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):